China's first online-only banking service provider is using big data technology to grant loans to SMBs and rural customers.
After almost nine months of preparation, e-commerce giant Alibaba has revealed the latest addition to its online financial services network by officially launching the Zhejiang Wangshang Bank.
BOSTON, Jun 24, 2015 (GLOBE NEWSWIRE via COMTEX) -- Keryx Biopharmaceuticals, Inc. KERX, +0.63% a biopharmaceutical company focused on bringing innovative therapies to market for people with renal disease, today announced that two national insurance providers have added Auryxia™ to their Medicare Part D formularies. Auryxia is the first and only absorbable, iron-based phosphate binder for the treatment of elevated serum phosphorus levels in people with chronic kidney disease on dialysis. Together, these new formularies will increase unrestricted access to Auryxia, across Medicare Part D and commercial insurance providers, to approximately 65 percent of people in the U.S. currently taking phosphate binders.
Parkinson's disease (PD) has been found to be associated with 16 types of cancer in a study in Taiwan.
Women ages 50 to 69 years who attend mammography screening reduce their risk of dying from breast cancer by 40% compared with women who are not screened, according to a major international review of the latest evidence on breast cancer screening. This review was published in the New England Journal of Medicine
